|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Patento numeris | 3473648 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18206830.4 |
| Europos patento paraiškos padavimo data | 2015-01-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461930582 P | 2014-01-23 | US | |
| 201462089549 P | 2014-12-09 | US |
| (72) |
PAPADOPOULOS, Nicholas, J. , US
MURPHY, Andrew, J. , US
THURSTON, Gavin , US
IOFFE, Ella , US
BUROVA, Elena , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | HUMAN ANTIBODIES TO PD-L1 |
| HUMAN ANTIBODIES TO PD-L1 |